封面
市場調查報告書
商品編碼
1957250

自動化樣品製備市場-全球產業規模、佔有率、趨勢、機會、預測:按應用、產品類型、最終用戶、地區和競爭格局分類,2021-2031年

Automated Sample Preparation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Product Type, By End-User, By Region & Competition, 2021-2031F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球自動化樣品製備市場預計將從 2025 年的 24.2 億美元成長到 2031 年的 43.1 億美元,複合年成長率為 10.10%。

自動化樣品製備是指在分析檢體之前,利用機器人系統和軟體協調生物或化學樣本的萃取、純化和處理過程。該市場的主要促進因素包括迫切需要提高可重複性並減少可能威脅資料完整性的人為錯誤。此外,藥物研發和臨床診斷領域對快速處理能力的需求日益成長,也要求系統能夠以符合現代實驗室標準的速度和精度處理大量樣本。

市場概覽
預測期 2027-2031
市場規模:2025年 24.2億美元
市場規模:2031年 43.1億美元
複合年成長率:2026-2031年 10.1%
成長最快的細分市場 測量儀器
最大的市場 北美洲

隨著實驗室不斷努力提高效率,採用先進技術已成為市場發展的關鍵要素。根據皮斯托亞聯盟2024年的數據,68%的受訪生命科學專業人士在其工作​​流程中積極使用人工智慧(AI)和機器學習,這表明智慧自動化系統能夠簡化複雜流程,並已形成良好的推廣環境。然而,將這些平台與現有傳統基礎設施整合的複雜性是其廣泛應用的主要障礙。此外,此類大型系統所需的大量前期投資也令小規模實驗室望而卻步,儘管其營運優勢顯而易見,但這可能會延緩其普及。

市場促進因素

製藥和生物技術公司研發投入的增加是全球自動化樣品製備市場的主要驅動力。隨著藥物發現日益複雜,主要企業正投入創紀錄的研發資金,以加速潛在候選藥物的發現。資金的湧入推動了自動化解決方案的普及,因為這需要部署能夠快速、準確地篩檢龐大化合物庫的高通量系統。例如,強生公司在其於2024年1月發布的2023年第四季及全年財報中披露,為推動產品線創新,公司在研發方面投入了創紀錄的151億美元。如此龐大的投資凸顯了依賴自動化工作流程的緊迫性,透過加快研發進度和確保早期篩檢階段的資料可靠性,可以最佳化投資報酬率。

同時,人們對提高營運效率和降低人事費用的日益關注正在改變實驗室的管理方式。各機構擴大採用自動化技術,以緩解熟練人員短缺的影響,並消除人工操作帶來的不一致。西門子醫療於2024年7月對美國實驗室專業人員進行的一項調查顯示,89%的受訪者認為自動化對於有效管理不斷成長的檢測量至關重要。透過將重複性任務委託給機器人系統,檢查室可以顯著提高處理能力,同時減少人為錯誤。根據Dispendix在2024年11月發布的報告顯示,次世代定序(NGS)的自動化已被證實可將人工檢體處理的需求減少高達80%,使科學家能夠專注於高價值的分析和結果解讀。

市場挑戰

大規模自動化樣品製備系統所需的大量前期投資是全球自動化樣品製備市場的主要阻礙因素。儘管這些平台在可重複性和速度方面具有優勢,但高昂的前期投資阻礙了大多數潛在用戶,尤其是中小企業和學術研究機構,放棄手動方法。這項財務障礙不僅包括硬體購置成本,還包括軟體整合、專業人員培訓和持續維護等相關費用,造成複雜的預算障礙,延緩採購決策並限制市場滲透。

資金限制仍然是先進實驗室技術廣泛應用的一大障礙。根據皮斯托亞聯盟2024年的報告,在接受調查的生命科學專業人士中,20%的人認為資金障礙是採用新技術的主要阻礙,這一比例比前一年增加了數十億以金額為準。這種對價格承受能力日益成長的擔憂凸顯出,儘管智慧自動化系統具有許多操作優勢,但預算限制仍然直接阻礙了其普及應用。因此,成本敏感型細分市場的成長率正在放緩,而資金雄厚的製藥巨頭對技術的採用有限,也導致整體潛在市場規模萎縮。

市場趨勢

永續で環境に配慮したサンプル調製技術への移行は、研究所が環境負荷低減を目指す中で製品開発に影響を与えています。この動向は、厳格な企業治理要件への適合を図るため、消耗品由来のプラスチック廢棄物の削減や自動化機器のエネルギー使用量低減を重視するものです。メーカー各社はこうした優先順位の変化に対応すべく、環境に優しいシステムの設計を積極的に進めています。この業界の取り組みは、2024年11月にMy Green Labが発表した「2024年バイオテック,製薬業界のカーボンインパクト報告書」で数値化されており、分析対象企業の31%が1.5度C目標に沿った中期的なスコープ1および2の排放削減目標を設定していることが示されました。これに伴い、ベンダー各社は試薬消費量を削減するためのワークフロー再構築や、永續な運営への需要増に対応する循環型経済の概念導入を進めています。

同時,對複雜微量樣本進行高靈敏度處理的需求正推動基因組學和蛋白​​質組學工作流程自動化程度的提高。現代平台已超越簡單的液體處理,以滿足次世代定序(NGS) 的嚴格要求。精確的微量分裝對於維持樣本完整性至關重要,而這項技術進步使得以往只能手動操作的複雜通訊協定得以自動化。例如,貝克曼庫爾特生命科學公司於 2024 年 4 月宣布,其與 Watchmaker Genomics 合作開發的自動化 RNA 文庫製備方法能夠處理低至 1 ng 的樣本量,這便是靈敏度提升的一個具體例證。這凸顯了市場正朝著先進自動化方向發展,以極少量的生物材料獲得高度精確的結果。

目錄

第1章概述

第2章:調查方法

第3章執行摘要

第4章:客戶心聲

第5章:全球自動化樣品製備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按應用領域(研發、診斷)
    • 產品類型(試劑盒/耗材、設備)
    • 按最終用戶分類(生物技術和製藥公司、臨床和診斷檢查室、學術和研究機構)
    • 按地區
    • 按公司(2025 年)
  • 市場地圖

第6章:北美自動化樣品製備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲:國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲自動化樣品製備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲:國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章:亞太地區自動化樣品製備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區:國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:中東和非洲自動化樣品製備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲:國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章:南美洲自動化樣品製備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲:國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章:全球自動化樣品製備市場:SWOT分析

第14章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Agilent Technologies, Inc.
  • Aurora Biomed Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Metrohm AG
  • Mettler-Toledo International Inc
  • MGI Tech Co., Ltd.
  • Promega Corporation
  • QIAGEN NV
  • Revvity, Inc.

第16章 策略建議

第17章:關於研究公司及免責聲明

簡介目錄
Product Code: 24108

The Global Automated Sample Preparation Market is projected to expand from USD 2.42 billion in 2025 to USD 4.31 billion by 2031, reflecting a compound annual growth rate of 10.10%. Automated sample preparation involves the use of robotic systems and software to orchestrate the extraction, purification, and management of biological or chemical specimens ahead of analytical testing. The primary forces propelling this market include the urgent need for enhanced reproducibility and the mitigation of manual errors that threaten data integrity. Furthermore, the escalating requirement for rapid throughput in drug discovery and clinical diagnostics demands systems that can manage substantial sample volumes with the speed and precision necessary to satisfy contemporary laboratory standards.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.42 Billion
Market Size 2031USD 4.31 Billion
CAGR 2026-203110.1%
Fastest Growing SegmentInstruments
Largest MarketNorth America

The incorporation of sophisticated technologies is a crucial element in market development as laboratories aim for heightened efficiency. Data from the Pistoia Alliance in 2024 reveals that 68% of life science experts surveyed are actively utilizing Artificial Intelligence and Machine Learning in their workflows, indicating a favorable climate for adopting intelligent automated systems that simplify complex processes. Nevertheless, a major obstacle hindering widespread growth is the complexity of merging these platforms with established legacy infrastructures. Additionally, the substantial initial capital investment needed for such extensive systems creates a hurdle for smaller laboratories, potentially delaying universal adoption despite the evident operational advantages.

Market Driver

Increasing research and development investments by pharmaceutical and biotechnology companies serve as a major driver for the Global Automated Sample Preparation Market. As the complexity of drug discovery intensifies, leading industry participants are allocating record amounts of capital toward research to expedite the discovery of potential therapeutic candidates. This influx of funding requires the implementation of high-throughput systems capable of screening extensive compound libraries with both speed and accuracy, thereby fostering the adoption of automated solutions. For example, Johnson & Johnson reported in their 'Fourth-Quarter and Full Year 2023 Results' in January 2024 a historic R&D investment of $15.1 billion to fuel pipeline innovation. Such significant financial outlays highlight the essential reliance on automated workflows to optimize return on investment by accelerating development schedules and guaranteeing data reliability during early-stage screening.

Concurrently, the growing emphasis on operational efficiency and the reduction of labor costs is transforming laboratory management approaches. Facilities are frequently adopting automation to alleviate the effects of skilled staff shortages and to remove the inconsistencies linked to manual handling. A July 2024 survey of U.S. laboratory professionals by Siemens Healthineers found that 89% of respondents believe automation is necessary to effectively manage rising testing volumes. By assigning repetitive duties to robotic systems, laboratories can drastically increase throughput while reducing human error. According to Dispendix in November 2024, the incorporation of Next-Generation Sequencing (NGS) automation has demonstrated the ability to decrease manual sample processing requirements by up to 80%, enabling scientists to shift their attention to high-value analysis and the interpretation of results.

Market Challenge

The substantial initial capital required for extensive automated sample preparation systems serves as a major constraint on the Global Automated Sample Preparation Market. Although these platforms provide benefits in terms of reproducibility and speed, the significant upfront cost deters a large portion of prospective users, specifically small-to-medium-sized enterprises (SMEs) and academic research facilities, from moving away from manual methods. This financial barrier encompasses not only the hardware purchase but also costs related to software integration, specialized staff training, and continuous maintenance, resulting in a complicated budgetary obstacle that postpones procurement decisions and limits market reach.

Financial limitations persist as a quantifiable hindrance to the uptake of advanced laboratory technologies. In 2024, the Pistoia Alliance reported that 20% of surveyed life science professionals identified financial barriers as a principal challenge to adopting new technologies, representing an increase from the prior year. This growing apprehension regarding affordability underscores that, despite the operational benefits, budgetary constraints are directly impeding the universal deployment of intelligent automated systems. As a result, the market undergoes reduced growth rates in cost-sensitive segments, limiting the technology's reach to well-capitalized pharmaceutical leaders and decreasing the overall addressable market volume.

Market Trends

The transition toward sustainable and green sample preparation techniques is influencing product development as laboratories aim to reduce their environmental impact. This trend emphasizes cutting down on plastic waste from consumables and decreasing energy usage in automated instruments to comply with stringent corporate governance requirements. Manufacturers are actively designing eco-friendly systems to match these shifting priorities. This industry commitment is quantified by the '2024 Carbon Impact of Biotech & Pharma Report' from My Green Lab in November 2024, which noted that 31% of analyzed firms have established medium-term Scope 1 and 2 targets consistent with a 1.5°C pathway. Accordingly, vendors are restructuring workflows to lower reagent consumption and applying circular economy concepts to meet the growing demand for sustainable operations.

At the same time, the broadening of automation within genomic and proteomic workflows is being propelled by the need to handle complex, low-input samples with high sensitivity. Contemporary platforms are advancing past simple liquid handling to address the exacting requirements of Next-Generation Sequencing (NGS), where accurate low-volume dispensing is essential for maintaining sample integrity. This technological progression enables researchers to automate intricate protocols that were formerly restricted to manual performance. Illustrating this improvement in sensitivity, Beckman Coulter Life Sciences announced in April 2024, regarding their collaboration with Watchmaker Genomics, that their co-developed automated RNA library preparation method successfully accommodates input quantities as low as 1 ng. This highlights the market's shift toward advanced automation that facilitates high-fidelity outcomes from minimal biological material.

Key Market Players

  • Agilent Technologies, Inc.
  • Aurora Biomed Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Metrohm AG
  • Mettler-Toledo International Inc
  • MGI Tech Co., Ltd.
  • Promega Corporation
  • QIAGEN N.V.
  • Revvity, Inc.

Report Scope

In this report, the Global Automated Sample Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Automated Sample Preparation Market, By Application

  • Research and Development
  • Diagnostics

Automated Sample Preparation Market, By Product Type

  • Kits and Consumables
  • Instruments

Automated Sample Preparation Market, By End-User

  • Biotechnology and Pharmaceutical Companies
  • Clinical and Diagnostic Laboratories
  • Academic
  • Research Institutions

Automated Sample Preparation Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Automated Sample Preparation Market.

Available Customizations:

Global Automated Sample Preparation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Automated Sample Preparation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Research and Development, Diagnostics)
    • 5.2.2. By Product Type (Kits and Consumables, Instruments)
    • 5.2.3. By End-User (Biotechnology and Pharmaceutical Companies, Clinical and Diagnostic Laboratories, Academic, Research Institutions)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Automated Sample Preparation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Product Type
    • 6.2.3. By End-User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Automated Sample Preparation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By End-User
    • 6.3.2. Canada Automated Sample Preparation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By End-User
    • 6.3.3. Mexico Automated Sample Preparation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By End-User

7. Europe Automated Sample Preparation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Product Type
    • 7.2.3. By End-User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Automated Sample Preparation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By End-User
    • 7.3.2. France Automated Sample Preparation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By End-User
    • 7.3.3. United Kingdom Automated Sample Preparation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By End-User
    • 7.3.4. Italy Automated Sample Preparation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By End-User
    • 7.3.5. Spain Automated Sample Preparation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By End-User

8. Asia Pacific Automated Sample Preparation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Product Type
    • 8.2.3. By End-User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Automated Sample Preparation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By End-User
    • 8.3.2. India Automated Sample Preparation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By End-User
    • 8.3.3. Japan Automated Sample Preparation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By End-User
    • 8.3.4. South Korea Automated Sample Preparation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By End-User
    • 8.3.5. Australia Automated Sample Preparation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By End-User

9. Middle East & Africa Automated Sample Preparation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Product Type
    • 9.2.3. By End-User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Automated Sample Preparation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By End-User
    • 9.3.2. UAE Automated Sample Preparation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By End-User
    • 9.3.3. South Africa Automated Sample Preparation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By End-User

10. South America Automated Sample Preparation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Product Type
    • 10.2.3. By End-User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Automated Sample Preparation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By End-User
    • 10.3.2. Colombia Automated Sample Preparation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By End-User
    • 10.3.3. Argentina Automated Sample Preparation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Automated Sample Preparation Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Agilent Technologies, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Aurora Biomed Inc.
  • 15.3. Danaher Corporation
  • 15.4. F. Hoffmann-La Roche Ltd
  • 15.5. Metrohm AG
  • 15.6. Mettler-Toledo International Inc
  • 15.7. MGI Tech Co., Ltd.
  • 15.8. Promega Corporation
  • 15.9. QIAGEN N.V.
  • 15.10. Revvity, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer